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Abstract
Campylobacter jejuni is a major cause of bacterial gastroenteritis worldwide, and the capsular polysaccharide (CPS) of this
organism is required for persistence and disease. C. jejuni produces over 47 different capsular structures, including a unique
O-methyl phosphoramidate (MeOPN) modification present on most C. jejuni isolates. Although the MeOPN structure is rare
in nature it has structural similarity to some synthetic pesticides. In this study, we have demonstrated, by whole genome
comparisons and high resolution magic angle spinning NMR, that MeOPN modifications are common to several
Campylobacter species. Using MeOPN biosynthesis and transferase mutants generated in C. jejuni strain 81–176, we
observed that loss of MeOPN from the cell surface correlated with increased invasion of Caco-2 epithelial cells and reduced
resistance to killing by human serum. In C. jejuni, the observed serum mediated killing was determined to result primarily
from activation of the classical complement pathway. The C. jejuni MeOPN transferase mutant showed similar levels of
colonization relative to the wild-type in chickens, but showed a five-fold drop in colonization when co-infected with the
wild-type in piglets. In Galleria mellonella waxmoth larvae, the MeOPN transferase mutant was able to kill the insects at wild-
type levels. Furthermore, injection of the larvae with MeOPN-linked monosaccharides or CPS purified from the wild-type
strain did not result in larval killing, indicating that MeOPN does not have inherent insecticidal activity.
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Introduction
Campylobacter jejuni is a Gram-negative bacterium that is a
leading cause of bacterial gastroenteritis worldwide [1]. The
handling and consumption of contaminated poultry are the most
common routes of infection in developed countries [2], although
contaminated water and dairy products can also be significant
sources [3]. In developing countries, campylobacteriosis is
endemic and represents a major cause of diarrheal disease and
infant mortality. Symptoms of infection typically range from mild
to severe inflammatory diarrhea, but in rare cases infection leads
to the life-threatening autoimmune disorder known as the
Guillain-Barre´ syndrome [4].
Capsular polysaccharide (CPS) forms the outermost structure
on most bacteria and plays key roles in the interaction between the
organism, host, and environment. In the case of C. jejuni, CPS is
the major determinant of the Penner serotyping scheme [5] and
has been demonstrated to be important for both serum resistance
and invasion of epithelial cells [6]. The CPS produced by C. jejuni
strains are structurally complex and highly variable, due in part to
the addition of phase-variable modifications such as O-methyl,
ethanolamine, aminoglycerol, and O-methyl phosphoramidate
(MeOPN) groups [7,8,9]. Although phosphoramidates are rare
in nature, our previous studies identified the presence of MeOPN
modifications in ,70% of C. jejuni isolates [10]. In C. jejuni strain
11168H, we identified four genes required for the biosynthesis of
MeOPN, cj14152cj1418, and two phase variable genes, cj1421
and cj1422, that encode transferases responsible for the addition of
MeOPN to C-3 of b-D-GalfNAc or to C-4 of D-glycero-a-L-gluco-
Hep, respectively [10].
While it is unknown whether MeOPN modifications are present
in other Campylobacteraceae, their commonality among C. jejuni
strains suggests an important biological role for these surface-
expressed modifications within the species, and we have recently
demonstrated that MeOPN is a receptor for several C. jejuni lytic
bacteriophages [11,12]. MeOPN has structural similarity to some
synthetic pesticides [13], and infection studies with C. jejuni
11168H in the Galleria mellonella model showed a substantial
decrease in insecticidal activity for a MeOPN biosynthesis mutant
relative to the wild-type strain [14]. More recently, Maue et al.
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[15] demonstrated that disruption of a MeOPN biosynthetic gene
in the virulent C. jejuni 81–176 strain correlated to reductions in
both serum resistance and colonization in a mouse intestinal
model, relative to the wild-type strain. In combination, these
studies indicate that, when present, MeOPN biosynthesis is
important for C. jejuni cellular interactions and infection.
In this study, we have determined that MeOPN modifications
are prevalent among several Campylobacter species, and not limited
to C. jejuni. We have mutated the MeOPN transferase gene
homologues in C. jejuni strains 81–176 and 11168H. Both mutants
exhibited similar levels of insecticidal activity compared to wild-
type in the G. mellonella infection model, and no insecticidal activity
was observed when G. mellonella was injected with either purified
CPS or synthesized compounds containing MeOPN. However,
the MeOPN mutant exhibits enhanced invasion of Caco-2 cells
and reduced resistance to serum, primarily due to activation of the
classical complement pathway. The mutant shows no difference in
colonization of chickens compared to the wild-type, but the
mutant shows a drop in colonization in piglets in co-infection
studies with the wild-type. Our data suggests that, when present,
MeOPN has a contributory role in pathogenesis.
Materials and Methods
Reagents, Strains, Plasmids and Growth Conditions
Unless otherwise specified, all reagents were obtained from
Sigma-Aldrich Canada (Oakville, ON), and all media were
obtained from Difco Laboratories (Detroit, MI). Restriction
enzymes were obtained from New England Biolabs (Herts, UK)
and T4 DNA ligase was obtained from Promega (Southampton,
UK). All Campylobacter strains (Table 1) were grown under
microaerobic conditions (10% CO2, 5% O2, 85% N2) at 37uC.
For NMR experiments, Campylobacter strains were grown on Brain
Heart Infusion agar supplemented with 5% (v/v) defibrinated
horse blood. Otherwise, C. jejuni 81–176 wild-type and mutant
strains were routinely propagated on Mueller-Hinton (MH) agar
or in MH broth with agitation at 100 r.p.m. Where appropriate,
media were supplemented with 30 mg ml21 kanamycin (Km) and
20 mg ml21 chloramphenicol (Cm).
Campylobacter Speciation/screening for Orthologues of
cj1416–1418
Thirty-one proteomes, predicted from the complete or draft
genomes of all current, validly-described Campylobacter taxa
(Table 1), were combined into a FASTA-formatted file, which
was then used to construct the binary files for a BLASTP database.
This database was queried using BLASTP and the protein
sequences of C. jejuni strain NCTC 11168 loci Cj1416-Cj1418.
Positive matches were scored as those matches with .35%
similarity and an alignment length across either the query or
match sequences of .75%.
High Resolution Magic Angle Spinning (HR-MAS) NMR
Spectroscopic Analysis of Campylobacter Strains
The methods were followed as previously described [7], with
minor modifications. Except where noted, all HR-MAS spectra
were acquired in D2O on a 600 MHz spectrometer, equipped
with a 1H{15N–31P} 4 mm pulsed field gradient (PFG) indirect-
detection nanoprobe. The first increment of 1H–31P heteronuclear
signal quantum correlation spectra (1D HSQC spectra) were
acquired with the transients noted: 1780 for C. insulaenigrae
RM5435; 2048 for C. lari UPTC NCTC 11845; 12,288 for C.
lari subsp. concheus LMG 11760; 1320 for C. subantarcticus RM8523;
1532 for C. cuniculorum LMG 24588; 3072 for C. upsaliensis
RM3940; 512 for C. upsaliensis RM3195, C. helveticus CCUG
30566, C. jejuni NCTC 11168, and the C. jejuni 81–176
cjj81176_1415 mutant; 256 for C. jejuni 81–176 and the C. jejuni
81–176 cjj81176_1420/cjj81176_1435 mutant. Note that the
spectrum for the C. jejuni 81–176 cjj81176_1415 mutant was
obtained on a 500 MHz spectrometer.
Construction of a MeOPN Transferase Knockout Mutant
in C. jejuni 81–176
The cjj81176_1420 and cjj81176_1435 genes of C. jejuni 81–176
(Genome accession number: NC_008787) were disrupted by
insertional inactivation and allelic replacement. Briefly,
cjj81176_1420 and cjj81176_1435 were PCR amplified using the
primer pairs ak265/ak266 and ak265/267 with the following
sequences: ak265:59-GCTCTAGAAGGAGTTTAAAATGTA-
TAACCCAAACTCAGCTATAGAAAGAG-39; ak266:59-
GCTCTAGATTACAAATCTTTTTCCTGAATATCAC-
CATCCAAC-39; ak267:59-GCTCTAGACTATGTTT-
TAATTTCTTTATAACTATACCAATTTTTAC-39. The
1.8 kb PCR products were cloned into the pGEM-T Easy vector
(Promega). After confirmation of the inserts via restriction analysis,
the recombinant plasmids were used for construction of kanr and
camr derivatives for insertional inactivation of genes cjj81176_1420
and cjj81176_1435, respectively. The blunt-ended BamHI frag-
ment of pJMK30 (sourse of the kanr cassette) was inserted into a
unique HindIII site (after blunt-ending) of cjj81176_1420, whilst
the camr cassette-carrying the SmaI fragment of plasmid pAV35
was inserted into a unique SwaI site of gene cjj81176_1435 [16].
Orientations of the camr and kanr cassettes were verified using
restriction analysis to make sure that the antibiotic resistance genes
are in colinear orientation with the target genes. The latter is
essential for prevention of a negative polar effect.
After transformation of the cjj81176_1420::kanr derivative into
81–176 and selection of colonies on a Km plate (50 mg ml21) the
products of recombination were confirmed by PCR using primers
ak265/ak266. The derived 81–176 cjj81176_1420::kanr mutant
was then used for insertional inactivation of gene
cjj81176_1435 via trasformation with the cjj81176_1435::camr
construct and selection of recombinant clones on plates supple-
mented with both Km (50 mg ml21) and Cm (10 mg ml21). The
resultant cjj81176_1420::kanr/cjj81176_1435::camr MeOPN trans-
ferase double mutant isolates were verified by PCR with ak265/
266, ak265/ak267 and ak265 with ak237 (reverse primer within
the canr cassette; 59-TCCTGAACTCTTCATGTCGATTG-39)
producing products of 3.3 kb, 2.7 kb and 1.4 kb respectively as
expected. Several independent confirmed clonal isolates were
stored in 50% glycerol at 280uC.
Construction of a MeOPN Biosynthesis Knockout Mutant
in C. jejuni 81–176
The cjj81176_1415 gene of C. jejuni 81–176 was disrupted by
insertional inactivation and allelic replacement. Briefly, a muta-
genesis construct was generated by PCR amplification of the
disrupted cj1416-kanr gene from the 11168H cj1416 mutant we
used previously [10] (and also used by Champion et al. [14]) using
primers CS-350 (59- CACTAAATCAGCCTCTGGTTTATC-39)
and CS-351 (59- AAAAGAAGATTTGGCTCATCTTG-39), fol-
lowed by ligation of the 3.2 kb PCR product into the pGEM-T
Easy vector (Promega). After natural transformation of the
cjj81176_1415::kanr derivative into 81–176 and selection of
colonies on a BHI-Blood Km agar plate (25 mg ml21 Km), 81–
176 cjj81176_1415::kanr mutant isolates were verified by PCR
Biological Roles of the C. jejuni Phosphoramidate
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using the CS-350/CS-351 primer pair, producing a 3.2 kb
product as expected.
Reverse Transcriptase PCR
Reverse transcriptase PCR experiments were performed with
wildtype and mutant strains to examine whether transcript levels
of genes located immediately downstream from insertionally
disrupted genes were affected in the MeOPN biosynthesis and
MeOPN transferase knockout mutant strains used in this study
(Fig. S1). Total RNA extracts were obtained from C. jejuni 11168H
and 81–176 wildtype, 11168H cj1420::kanr mutant, 11168H
cj1421/cj1422::kanr mutant, 81–176 cjj81176_1415::kanr mutant,
and 81–176 cjj81176_1420::kanr/cjj81176_1435::camr mutant
strains using the AurumTM Total RNA Mini Kit (Bio Rad
Laboratories, Inc., Hercules, CA). First strand synthesis of cDNA
from RNA preparations was performed using the SuperScript III
First-Strand Synthesis system (Life Technologies, Carlsbad, CA),
using the following specific primers: CS-645 (59- CATTAGCTC-
GAGGTTTTTTTGATATTG-39) for cjj81176_1414 and cj1415;
CS-1247 (59- GGAATCTCTATACTTTGCATATG-39) for
cjj81176_1419 and cj1420; CS-1249 (59- GGACACTAACT-
CAAATGGTAG-39) for cjj81176_1434; CS-869 (59- ATGACTT-
GACGTCGTCCACACCTT -39) for 16S rRNA as an internal
control. PCR reactions were performed using resultant cDNA
preparations with Taq polymerase (Life Technologies) and the
following primer pairs: CS-644 (59- GAGGTGCCATAT-
Table 1. Bacterial strains.
Strain Description Ref/Source
Campylobacter avium LMG 24591T [28]
Campylobacter coli RM2228 [29]
Campylobacter concisus RH 13826.98 [30]
Campylobacter cuniculorum LMG 24588T (RM8641) [31]
Campylobacter curvus 525.92 Human oral isolate Al Lastovica
Campylobacter fetus subsp. fetus 82–40 [32]
Campylobacter fetus subsp. venerealis 97/608 [33]
Campylobacter gracilis ATCC 33236T [34]
Campylobacter helveticus CCUG 30566 (RM4087) Feline Stephen On
Campylobacter hominis ATCC BAA-381T [35]
Campylobacter hyointestinalis subsp. hyointestinalis LMG 9260 Human clinical Stephen On
Campylobacter hyointestinalis subsp. lawsonii CCUG 27631 Porcine Stephen On
Campylobacter insulaenigrae NCTC 12927T (RM5435) [36]
Campylobacter jejuni strains
11168H Hypermotile variant [37]
11168H Dcj1421-cj1422::kanr MeOPN transferase mutant [10]
81–176 [38]
81–176 cjj81176_1420::kanr/cjj81176_1435::camr MeOPN transferase mutant This study
81–176 kpsM::kanr acapsular mutant [6]
NCTC 11168 [39]
Campylobacter lanienae NCTC13004T [40]
Campylobacter lari subsp. concheus LMG 11760 (RM2825) [41]
Campylobacter lari subsp. lari RM2100 [29]
Campylobacter lari (UPTC) NCTC 11845 (RM3659) [42]
Campylobacter mucosalis CCUG 21559 [43]
Campylobacter peloridis LMG 11251 [41]
Campylobacter rectus ATCC 33238T [34]
Campylobacter showae ATCC 51146T [44]
Campylobacter sputorum bv. fecalis CCUG 20703 [45]
Campylobacter sputorum bv. paraureolyticus LMG 11764 [45]
Campylobacter sputorum bv. sputorum RM3237 Unknown Unknown
Campylobacter subantarcticus LMG 24377T (RM8523) [46]
Campylobacter upsaliensis RM3195 [29]
Campylobacter upsaliensis RM3940 [47]
Campylobacter ureolyticus RIGS9880 Human clinical Stephen On
Campylobacter volucris LMG 24379 [46]
Ttype strain.
doi:10.1371/journal.pone.0087051.t001
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GAAAAATAATCC-39) and CS-645 for cjj81176_1414 and
cj1415; CS-1246 (59- CAATAGACCTGCTTATAGTCC-39)
and CS-1247 for cjj81176_1419 and cj1420; CS-1248 (59-
GTAAAATACGTGGCTGTTGTC-39) and CS-1249 for
cjj81176_1434; CS-868 (59- GCGCAACCCACGTATT-
TAGTTGCT -39) and CS-869 for 16S rRNA as an internal
control. For each PCR reaction, a 75-ml reaction mix was
generated and aliquoted into 7 individual 10-ml aliquots. These
aliquots were placed in a thermocycler and subjected to PCR, with
individual aliquots being removed in 5-cylce increments from 5 to
35 cycles, and analyzed by agarose gel electrophoresis.
Adherence and Invasion Assays
The human Caco-2 epithelial cell line was obtained from the
American Type Culture Collection (ATCC HTB-37) and was
routinely grown in Dulbecco’s minimal essential medium
(DMEM) supplemented with 10% (v/v) fetal bovine serum,
2 mM L-glutamine and 1.0 mM sodium pyruvate and incubated
at 37uC in a humidified atmosphere with 5% CO2. Two days prior
to infection, cells were trypsinized and seeded into a 24-well plate
at 2.56105 cells ml21, according to the method of Oelschlaeger
et al. [17]. On the day of infection, Caco-2 cell medium was
replaced with infection medium (modified Eagle’s medium
supplemented with 2 mM L-glutamine, 1 mM sodium pyruvate,
and 1% fetal bovine serum) 1 h prior to addition of the bacteria.
Bacterial cells from an overnight culture were harvested by
centrifugation (3,0006g, 10 min, 20uC), washed with phosphate
buffered saline (PBS), and added to Caco-2 cells to a multiplicity of
infection of 100. After a 3 h incubation at 37uC in 5% CO2, Caco-
2 cells were rinsed with 361 ml of PBS, lysed with 250 ml of 0.1%
Triton X-100 in PBS (15 min, 20uC), and dilutions of each well
were plated on MH agar to yield combined adherence and
invasion numbers. Invasion levels were determined after a 3 h
incubation in 0.5 ml of medium containing 250 mg ml21 of
gentamicin (Gm), then extensive washing prior to lysis with Triton
X-100. Adherence values were determined by subtraction of the
invasion values from the combined adherence and invasion values.
Experiments were performed in duplicate and the averages (mean
6 SEM) of three separate experiments are presented, and
significance was assessed by an unpaired t-test.
Motility Assays
To assess the motility of the C. jejuni 81–176 cjj81176_1415::kanr,
cjj81176_1420::kanr/cjj81176_1435::camr and kpsM::kanr mutants
relative to the wild-type strain, sterile needles were dipped into
liquid cultures of each strain and stabbed into semi-solid medium
(thioglycollate medium containing 0.4% agar). Swarming was
assessed after incubation under microaerobic conditions at 37uC
for 24 h.
Serum Resistance Assays
Serum resistance assays were performed according to the
method of Blaser et. al. [18] with modifications. Briefly, C. jejuni
strains were grown for 16 h in biphasic MH medium, then washed
and resuspended in HEPES buffer (10 mM HEPES, 150 mM
NaCl, 5 mM CaCl2, 5 mM KCl, 5 mM MgCl2, 5 mM dextrose,
pH 7.4) to a final concentration of 106 CFU ml21. For each
culture, 100 ml aliquots of cell suspension were combined with
350 ml HEPES buffer and 50 ml of either fresh pooled normal
human complement serum (NHS) (Innovative Research, Inc,
Novi, MI) or heat-inactivated NHS (56uC for 45 min) (final serum
concentration of 10%). Aliquots were taken at 0 min, 30 min, and
60 min, and bacterial counts were enumerated via serial dilution
on MH agar. Bacterial survival in active serum was calculated as
percentage of survival in inactive serum. Experiments were
performed in triplicate and the averages (mean 6 SEM) of three
separate experiments are presented, and significance was assessed
by an unpaired t-test.
To determine if the classical complement activation pathway
was involved in the observed killing, serum resistance assays were
performed as above in both the presence and absence of 50 mM
EGTA and incubated as above for 60 min before serial dilution
and plating on MH to enumerate surviving bacteria. Experiments
were performed in triplicate and the averages (mean 6 SEM) of
three separate experiments are presented, and significance was
assessed by an unpaired t-test.
Chicken Colonization
Animal procedures were approved by the Biosciences Animal
Care and Use Committee at the University of Alberta. The
animals were maintained and used in accordance with the
recommendations of the Canadian Council on Animal Care.
Chickens were obtained from the Poultry Research Facility,
Department of Agriculture, Food and Nutrition Science, Univer-
sity of Alberta and separated into three groups of eight birds. C.
jejuni strains were grown overnight on MH agar with the
appropriate antibiotic. Bacteria were harvested in PBS and
adjusted to 107 CFU/ml. One-day-old chicks were infected by
oral gavage with 106 CFU of C. jejuni 81–176 wild-type and the
cjj81176_1420::kanr/cjj81176_1435::camr mutant in 100 ml of PBS
or with PBS alone. Chicks were euthanized 6 days post-infection
and the caecal content was aseptically removed, serially diluted in
PBS, and plated onto Karmali selective agar plates. Colonies were
counted after 2 days of incubation under microaerobic conditions
(10% CO2, 5% O2, 85% N2) at 37uC to determine colonization
levels.
Pig Colonization
Animal procedures were approved by the Animal Care and Use
Committee at the University of Ottawa. The animals were
maintained and used in accordance with the recommendations of
the Canadian Council on Animal Care. Five male, specific
pathogen free neonatal colostrum-deprived piglets were acquired
from the Canadian Food Inspection Agency and were allowed to
acclimatize for at least 24 h to their environment. Overnight
cultures of C. jejuni 81–176 wild-type and the cjj81176_1420::kanr/
cjj81176_1435::camr mutant were adjusted to an OD600 nm of 1.0,
combined to create a 1:1 ratio of mutant to wild-type, and were
diluted in fresh MH broth to a 10 ml culture of approximately
107 CFU/ml and used to inoculate each piglet. To confirm the
exact ratio of wild-type to mutant, samples of the inoculum were
serially diluted, plated on MH agar with and without Cm and
enumerated.
The piglets developed a severe infection and were euthanized
within 48 h post-infection. Samples were taken from the
duodenum, jejunum, ileum, cecum, and colon, were homoge-
nized, serially diluted in MH broth and plated onto Campylo-
bacter agar base (Oxoid CM935) containing Campylobacter-
selective Karmali supplements (Oxoid SR167E) with and without
a 10 mg ml21 kanamycin supplement for the selection of the
cjj81176_1420::kanr/cjj81176_1435::camr mutant. The plates were
incubated at 37uC, under microaerobic conditions for 48 h and C.
jejuni colonies were counted to determine colonization levels.
Statistical significance was determined using a Mann2Whitney
test comparing the measured wild-type to mutant ratio of the
inoculum, to the ratio recovered from the piglet intestine following
infection (p= 0.0005).
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Galleria Mellonella Killing Assays
G. mellonella larvae (Bug Order Inc., Morinville, AB) were stored
at 4uC in woodchips until needed, and used within 7 days of being
received. Overnight cultures of C. jejuni (grown on MH agar) were
harvested and resuspended in 10 mM MgSO4 to a final
OD550 nm= 1.0 (,1.06109 cfu ml21). Stock solutions (10 mg
ml21) of synthesized MeOPN-linked monosaccharides (see below)
(Ashmus et al., in preparation) and 1 mg ml21 CPS were
prepared immediately prior to injection. After swabbing larvae
with ethanol, 5 ml aliquots of cell suspension or diluted compound
were injected into the left hindmost proleg using a 10 ml Hamilton
syringe. To prevent cross-contamination, the syringe was rinsed
sequentially with methanol then water between groups. After
injection, larvae were incubated at 37uC for 24 h, and survival
numbers recorded. Larvae that were not responsive to touch were
scored as dead. Campylobacter injection results represent the mean
(6SEM) of five independent experiments, MeOPN-containing
compound injection results represent the mean (6SEM) of four
independent experiments, and the 81–176 CPS injection data was
the result of a single experiment. In all cases, each individual
experiment consisted of three technical replicates, each containing
10 larvae.
Isolation of Capsular Polysaccharide
The CPS of C. jejuni 81–176 was purified according the
enzymatic isolation method of McNally et al. [8] to avoid the
partial loss of MeOPN modifications observed with phenol-based
methods.
Synthesis of MeOPN-linked Monosaccharides
The synthesis of methyl 2-O-(methylphosphoramidyl)-a-D-
glucopyranoside (2-MeOPN-Glc), methyl 6-O-(methylphosphora-
midyl)-a-D-glucopyranoside (6-MeOPN-Glc), methyl 2-O-(methyl-
phosphoramidyl)-a-D-galactopyranoside (2-MeOPN-Gal), and
methyl 6-O-(methylphosphoramidyl)-a-D-galactopyranoside (6-
MeOPN-Glc) will be described in a separate publication
(unpublished data).
Results
MeOPN Biosynthetic Genes are Prevalent Amongst
Campylobacter Species
Genetic analyses of representative members of the Campylobacter
genus resulted in the identification of orthologues to the C. jejuni
MeOPN biosynthesis genes cj1416–1418 in 13 of the 30 Campylo-
bacter strains analyzed (Fig. 1), with a high prevalence in strains
closely related to C. jejuni.
The Presence of MeOPN Biosynthetic Genes Correlates to
MeOPN Production for the Majority of Campylobacter
Species
A selection of the Campylobacter strains identified as containing
orthologues of cj1416-cj1418 were analyzed for the presence of
MeOPN by HR-MAS NMR, and resonances consistent with the
O-methyl group of MeOPN were observed in HSQC spectra of 9
of the 13 strains examined (Fig. 2). Signals corresponding to
MeOPN were not observed in C. fetus subsp. fetus 82.40, C. fetus
subsp. venerealis 97 608, C. lari subsp. lari RM2100, and C. sputorum
sputorum RM3237 (data not shown).
C. jejuni 81–176 Contains a Functional MeOPN
Biosynthesis Locus with Two Phase Variable Orthologues
of cj1422
To examine the biological role of MeOPN, we used the virulent
C. jejuni 81–176 strain. In silico analysis of the 81–176 genome led
to the identification of a locus (cjj81176_1414-cj81176_j1417) with
homology to the MeOPN biosynthesis locus of C. jejuni strain
NCTC 11168 (cj1415-cj1418), as well as two putative MeOPN
transferases (cjj81176_1420 and cj81176_j1435) with homology to
the cj1422 MeOPN transferase gene from NCTC 11168. Unlike
cj1421 and cj1422 in NCTC 11168, cjj81176_1420 and
cjj81176_1435 are not adjacent to each other and cjj81176_1435
is significantly downstream of the MeOPN biosynthesis locus but,
similar to cj1422, both contain polyG:C tracts, causing them to be
prone to phase variation. Sequencing results from our 81–
176 wild-type strain indicated that cjj81176_1435 is phased on
while cjj81176_1420 is phased off, but a cjj81176_1420::kanr/
cjj81176_1435::camr double knockout was nonetheless generated to
avoid any risk of cjj81176_1420 turning back on. HR-MAS NMR
analyses indicated the presence of a single MeOPN in the 81–
176 wild-type strain which was absent in the cjj81176_1420::kanr/
cjj81176_1435::camr MeOPN transferase mutant (Fig. 3).
Loss of MeOPN on the Cell Surface Results in Increased
Invasion of Epithelial Cells
To examine whether or not the presence of MeOPN on the cell
surface has a significant effect on adherence and invasion, the
ability of the cjj81176_1420::kanr/cjj81176_1435::camr mutant to
adhere to and invade Caco-2 cells, relative to both the wild-type
81–176 and the acapsular 81–176 kpsM::kanr mutant, was com-
pared. The cjj81176_1420::kanr/cjj81176_1435::camr mutant ex-
hibited similar adherence levels to wild-type, while the acapsular
kpsM::kanr mutant showed a nearly 10-fold decrease in adherence
relative to the wild-type strain (Fig. 4). These results indicate that
although the capsule is important for adherence, the presence of
MeOPN on the capsule is not. When invasion was assessed, the
cjj81176_1420::kanr/cjj81176_1435::camr mutant displayed a nearly
10-fold increase in invasion relative to wild-type, while the control
kpsM::kanr mutant invaded to significantly lower levels than wild-
type, as expected (Fig. 4). Motility assays were performed to
address the possibility that the differences observed between strains
were due to changes in motility, and no significant differences in
motility were observed between the three strains (data not shown).
To ensure that the observed changes in invasion were due to loss
of MeOPN, we also constructed a MeOPN biosynthesis mutant
(cjj81176_1415::kanr) with homology to cj1416 from NCTC 11168.
Similar to the MeOPN transferase mutant, the biosynthesis
mutant did not show a resonance for MeOPN in the HR-MAS
NMR analysis (Fig. 3 B) or a difference in motility or adherence,
but did show a statistically significant increase in invasion.
Loss of MeOPN from the Bacterial Surface Leads to a
Pronounced Decrease in Serum Resistance
Given that MeOPN on the cell surface of C. jejuni does not
enhance, but rather impairs the invasion process, we examined
whether MeOPN has any immunomodulatory effects that may be
beneficial in early stages of the infection process. When incubated
with normal human serum (NHS), the cjj81176_1415::kanr and
cjj81176_1420::kanr/cjj81176_1435::camr mutants and the acapsu-
lar kpsM::kanr mutant exhibited marked sensitivity to serum-
mediated killing relative to wild-type (Fig. 5), indicating that the
presence of MeOPN on the cell surface of C. jejuni provides
significant protection against the humoral immune system.
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The MeOPN Modifications on 81–176 CPS have a
Protective Influence Against Serum-mediated Killing via
the Classical Complement Activation Pathway
We speculated that the pronounced serum mediated killing
observed with the mutants was primarily due to the classical
pathway of complement activation since the commercial serum
that we used contained antibodies against C. jejuni (data not
shown). Therefore, we examined the effects of the presence or
absence of 50 mM EGTA on the level of serum resistance
observed (Fig. 6). The cjj81176_1420::kanr/cjj81176_1435::camr
mutant was unable to survive a 60 min incubation in serum assays
without EGTA, but ,100% survival was observed when EGTA
was included, indicating that the observed serum killing is indeed
primarily due to activation of the classical complement pathway.
Furthermore, the wild-type strain showed approximately 60%
survival in the absence of EGTA, but ,100% survival in the
Figure 1. Prevalence of MeOPN biosynthesis genes within the Campylobacter genus. Dendrogram of AtpA amino acid sequences of
representative Campylobacter species, with strains containing orthologues of the MeOPN biosynthesis genes (cj1416-1418) indicated with an asterisk.
The scale bar represents substitutions per site. Bootstrap values of .75%, generated from 1000 replicates using the Neighbor-Joining algorithm, are
shown in the nodes. The Cj1416-Cj1418 orthologues for C. jejuni, C. lari and C. fetus are present in the NCBI database: the accession number for C.
jejuni subsp. jejuni strain NCTC 11168 is AL111168; the accession number for C. coli strain 76339 (genes BN865_14280-14300) is HG326877; the
accession number for C. lari subsp. lari strain RM2100 (genes Cla_0314-316) is CP000932; the accession number for C. fetus subsp. fetus strain 82–40
(genes CFF8240_1630-1632) is CP000487; and the accession number for C. fetus subsp. venerealis strain NCTC 10354 (genes CFV354_1762-1764) is
CM001228. The accession numbers for the atp sequences and new Cj1416-Cj1418 orthologues from the other Campylobacter species are listed in
Table S1.
doi:10.1371/journal.pone.0087051.g001
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presence of EGTA, indicating that the presence of MeOPN offers
partial, but not complete, protection against serum killing via the
classical complement pathway.
Chicken Colonization Levels are not Affected by the
Presence or Absence of MeOPN on the Cell Surface
Because the presence of MeOPN on the cell surface of C. jejuni
negatively influences invasion of human Caco-2 cells, we
examined whether or not MeOPN has any effect on the ability
of C. jejuni to colonize chickens. No significant difference in
colonization levels was observed between the cjj81176_1420::kanr/
cjj81176_1435::camr mutant and the wild-type strain (Fig. 7),
suggesting that MeOPN does not play an important role in
chicken colonization.
MeOPN is Contributory to Piglet Colonization
While MeOPN was not found to play a role in colonization of
chickens, we examined the effects of MeOPN on colonization in
piglets. Due to inherent variation in colonization levels between
individual animals, competitive colonization assays were per-
formed allowing the relative colonization efficiencies of the
cjj81176_1420::kanr/cjj81176_1435::camr and wild-type strains in
an individual animal to be evaluated. The numbers of colonizing
bacteria were enumerated from samples of each section of the
intestine (duodenum, jejunum, ileum, cecum, and colon), and the
ratio of cjj81176_1420::kanr/cjj81176_1435::camr versus wild-type
recovered was determined. The mutant was significantly outcom-
peted by the wild-type strain with a 5-fold reduction in
colonization level (Fig. 7), indicating that the presence of MeOPN
plays a contributory role in piglet colonization.
MeOPN-containing Compounds and MeOPN-modified
CPS do not have Insecticidal Activity against G. mellonella
A recent study by Champion et al. [14] demonstrated that the
cj1416::kanr MeOPN biosynthetic mutant in C. jejuni 11168H
showed a marked reduction in killing of G. mellonella larvae
compared to wild-type, and that killing was restored in a
complemented mutant. These results suggested that MeOPN has
insecticidal activity, consistent with the fact that MeOPN has
similarity to some synthetic pesticides. We assessed the
cjj81176_1420::kanr/cjj81176_1435::camr mutant for the ability to
kill G. mellonella, because this mutant is not deficient in MeOPN
biosynthesis but is unable to transfer MeOPN to the capsule.
Interestingly, the cjj81176_1420::kanr/cjj81176_1435::camr mutant
was able to kill G. mellonella to similar levels as wild-type while the
acapsular kpsM::kanr mutant showed a significant decrease in
killing (Fig. 8 A). To investigate the possibility that this phenom-
enon is unique to the C. jejuni 81–176 background, the abilities of
wild-type C. jejuni 11168H and its MeOPN transferase mutant
(cj1421-cj1422::kanr) [10] to kill G. mellonella were also assessed. In
this background, the MeOPN transferase mutant in the C. jejuni
11168H background was also able to kill G. mellonella to similar
levels to the wild-type, indicating that the presence of MeOPN on
the CPS surface is not required for insecticidal activity for either C.
jejuni 11168H or C. jejuni 81–176. In contrast, both the C. jejuni 81–
176 cjj81176_1415::kanr and C. jejuni 11168H cj1416::kanr [10]
MeOPN biosynthesis mutants showed reduced killing of G.
mellonella (Fig. 8 B), consistent with Champion et al. [14].
Therefore, to more directly examine the insecticidal potential of
MeOPN, G. mellonella larvae were injected with chemically-
synthesized MeOPN-functionalized monosaccharides, and
MeOPN-containing CPS purified from the 81–176 wild-type
Figure 2. 1D 1H–31P HSQC spectra of select Campylobacter species containing orthologues of the cj1416-cj1418 genes. Spectra contain
the following resonances corresponding to MeOPN: C. insulaenigrae RM5435, peak at 3.74 ppm; C. lari UPTC NCTC 11845, peak at 3.70 ppm; C. lari
subsp. concheus LMG 11760, peak at 3.70 ppm; C. subantarcticus RM8523, peak at 3.75 ppm; C. cuniculorum LMG 24588, peak at 3.76 ppm; C.
upsaliensis RM3195, peak at 3.70 ppm; C. upsaliensis RM3940, peaks at 3.75 and 3.71 ppm; C. helveticus CCUG 30566, peak at 3.68 and 3.61 ppm; C.
jejuni NCTC 11168, peaks at 3.71 and 3.68 ppm.
doi:10.1371/journal.pone.0087051.g002
Figure 3. 1D 1H–31P HSQC analyses of C. jejuni 81-176 wild-type and the MeOPN biosynthesis and transferase mutants. Intact whole
cells of C. jejuni were analysed by HR-MAS NMR after 48 h growth on MH agar. Depicted are the 1D 1H–31P HSQC spectra, which specifically show the
MeOPN resonance at 3.8 ppm in 81-176 wt (A), but not in the cjj81176_1415::kanr MeOPN biosynthesis mutant (B), and cjj81176_1420::kanr/
cjj81176_1435::camr MeOPN transferase mutant (C).
doi:10.1371/journal.pone.0087051.g003
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strain. In all cases, these compounds showed no larval killing
relative to the PBS control (Fig. 8 C), indicating that the MeOPN
functionality is not inherently insecticidal against G. mellonella.
MeOPN Biosynthesis Mutants Show Reduced
Transcription of Downstream Gene
RT-PCR experiments were done on all four MeOPN biosyn-
thesis and transferase mutants to compare transcript levels of the
downstream genes (Fig. S1). Although all downstream genes were
transcribed, cjj1414::kanr in 81–176 and cj1415::kanr in 11168H
showed reduced expression compared to wild-type levels.
Discussion
Since our initial identification of MeOPN on the CPS of C. jejuni
NCTC 11168 [7], we have identified the genes involved in the
biosynthesis and transfer of this unusual modification, as well as
demonstrated that this modification is prevalent among most C.
jejuni isolates [10]. However, little is known regarding the
prevalence of this modification outside of C. jejuni and the
biological role of this modification is still not well understood. In
this study we sought to determine how common this modification
is among the Campylobacter genus and to further explore its
biological importance.
Genetic analyses of representative members of the Campylobacter
genus indicated that orthologues of the MeOPN biosynthetic
genes cj1416-cj1418 were not limited only to C. jejuni. Furthermore,
while these genes were most common among species more closely
related to C. jejuni (Fig. 1), they were absent in the C. coli strain that
we examined, which is somewhat surprising, given the close
relatedness of these two species and the rate of genetic exchange
between them [19,20], but these results are nonetheless consistent
with previous observations in which MeOPN was not detected for
any of the 18 C. coli isolates we examined [10]. It should be
pointed out however, that 3 other sequenced strains of C. coli,
including the type strain, do contain the cj1416-cj1418 ortholo-
gues, but no obvious cj1421/cj1422 orthologues. Twelve of the
Campylobacter species containing orthologous genes were analyzed
by HSQC HR-MAS NMR to screen for the presence of MeOPN,
and resonances consistent with MeOPN were observed for the
majority of Campylobacter strains screened (9 of 13). One possible
reason why we did not detect MeOPN in the other Campylobacter
species is that these strains could produce a phosphoramidate
lacking the O-methyl group, as has been observed in the
lipopolysaccharides of Xanthomonas campestris [21] and Shewanella
[22], because the diagnostic signal in the HSQC spectra is based
on detection of the protons in the O-methyl of the MeOPN group.
Alternatively, the MeOPN biosynthesis or transferase genes in
these strains could be phased off, given that the MeOPN
biosynthesis and transferase genes identified in both C. jejuni
11168H and C. jejuni 81–176 were found to be phase variable [10];
however, the cj1416-cj1418 orthologues of C. fetus subsp. fetus, C.
fetus subsp. venerealis, C. lari subsp. lari, and C. sputorum bv. sputorum
strains tested in this study do not contain GC tracts typically
associated with phase variability in Campylobacter. Most likely the
reason for not detecting MeOPN in these strains is due to the lack
of MeOPN transferase orthologues (cj1421 or cj1422) although it is
possible they may contain MeOPN transferase genes with low
similarity to cj1421 or cj1422.
To investigate the biological role of MeOPN, we used C. jejuni
81–176 due to the virulent nature of this strain. We generated
mutants that were deficient in both the biosynthesis and transfer of
MeOPN, to be confident that any effects observed could be
correlated specifically to loss of MeOPN, and confirmed that there
were no obvious changes to CPS besides the lack of MeOPN. The
identification of two orthologues of cj1422, with one phased off in
our 81–176 wild-type strain¸ is interesting because it is unclear
whether an isolate with both these genes phased on would display
a second distinct MeOPN modification or whether the transferases
play redundant roles. The published structure of the 81–176 CPS
indicates only one MeOPN modification [23,24], but it is not
known whether both transferases are functional in this back-
Figure 4. Loss of MeOPN results in increased invasion of Caco-
2 cells. Adherence and invasion of Caco-2 cells by C. jejuni 81-176 wild-
type, cj j81176_1415 : :kanr (MeOPN biosynthesis mutant) ,
cjj81176_1420::kanr/cjj81176_1435::camr (MeOPN transferase mutant),
and kpsM::kanr (capsule mutant) in the gentamicin protection assay.
Note that a significant difference (p#0.05, unpaired t-test) in adherence
was observed between C. jejuni 81-176 wild-type and the kpsM::kanr
mutant, and significant differences in invasion were observed between
the C. jejuni wild-type, and the cjj81176_1415::kanr (MeOPN biosynthesis
mutant), cjj81176_1420::kanr/cjj81176_1435::camr and kpsM::kanr mu-
tants. Results represent the mean (6 SEM) of three independent
experiments.
doi:10.1371/journal.pone.0087051.g004
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ground. To avoid potential confusion due to phase variation, we
generated a mutant with both of these genes disrupted.
We first examined whether or not the presence/absence of
MeOPN on the cell surface affects the adherence/invasion and
serum resistance of C. jejuni. The results obtained from the assays
indicated that MeOPN influences the ability of C. jejuni to invade
and resist serum killing. It is noteworthy that the serum resistance
results with the cjj81176_1420::kanr/cjj81176_1435::camr mutant
are consistent with those recently reported by Maue et al. [15] with
a C. jejuni 81–176 MeOPN biosynthetic mutant, which we also
tested. Because C. jejuni is primarily considered a gastrointestinal
pathogen, these results are relevant as they indicate that CPS
MeOPN modifications play a role in protection against humoral
immunity. However, because C. jejuni can also cause bacteremia
[25], these observations may be directly relevant to infections in
this context. To better understand the mechanisms underlying the
improved serum resistance of wild-type 81–176 versus the
MeOPN transferase mutant, we examined what effect, if any,
the addition of EGTA to serum assays would have on bacterial
survival. EGTA is a chelator with high selectivity for Ca2+;
therefore, the addition of EGTA acts as an effective inhibitor of
the classical pathway of complement activation, which is Ca2+-
dependent [26]. The effect of EGTA addition was drastic in the
case of the MeOPN mutant, which was unable to survive a 60 min
incubation with serum in the absence of EGTA but showed
,100% survival when EGTA was added, indicating that the
serum killing observed is mediated primarily via the classical
complement pathway. This is consistent with our observation that
the commercial serum that we used contained C. jejuni antibodies.
The intermediate level of serum survival observed with the wild-
type strain in the absence of EGTA indicates that the CPS
MeOPN modifications offer a moderate degree of protection by
interfering with serum killing.
The phase variability of the cjj81176_1420 and cjj81176_1435
genes suggests that MeOPN expression is desirable early in the
infection process for protection against humoral immunity, but
that phase variation to a MeOPN2 phenotype later in the
infection process would be beneficial and enhance the invasiveness
and virulence of C. jejuni. Interestingly, the C. jejuni NCTC 11168
variant that we isolated, which became bacteriophage resistant
through the loss of MeOPN [11], also showed increased
invasiveness relative to the parental strain (M.C. Holst-Sorensen
et al., unpublished data). It is not yet clear whether or not the
presence of MeOPN enhances serum resistance by preventing
antibody deposition, by inhibiting binding by CRP or another
acute phase serum protein, or by functioning through another
Figure 5. Loss of MeOPN results in a decrease in serum resistance. Survival of C. jejuni 81-176 wild-type, cjj81176_1415::kanr (MeOPN
biosynthesis mutant), cjj81176_1420::kanr/cjj81176_1435::camr (MeOPN transferase mutant), and kpsM::kanr (capsule mutant) in 10% natural human
complement serum relative to survival in heat inactivated serum. Serum resistance was significantly different between C. jejuni 81-176 wild-type, the
cjj81176_1415::kanr (MeOPN biosynthesis mutant), and the cjj81176_1420::kanr/cjj81176_1435::camr mutant at both 30 and 60 min (p,0.0001). Serum
resistance was significantly different between C. jejuni 81-176 wild-type and the kpsM::KmR mutant at both 30 and 60 min (p = 0.005 and p=0.014,
respectively) using an unpaired t-test. Results represent the mean (6 SEM) of three independent experiments.
doi:10.1371/journal.pone.0087051.g005
Figure 6. MeOPN modifications provide protection against
serum mediated killing by interfering with the classical
complement activation pathway. Survival of C. jejuni 81-176 wild-
type and cjj81176_1420::kanr/cjj81176_1435::camr (MeOPN transferase
mutant) in 10% natural human complement serum. The samples were
tested in the presence or absence of 50 mM EGTA after 60 min
incubation, relative to survival in heat inactivated serum. Serum
resistance was significantly different between C. jejuni 81-176 wild-type
in the presence versus absence of EGTA (p = 0.0030), the
cjj81176_1420::kanr/cjj81176_1435::camr mutant in the presence versus
absence of EGTA (p = 0.0014), and the 81-176 wild-type versus the
cjj81176_1420::kanr/cjj81176_1435::camr mutant in the absence of EGTA
(p = 0.0047) using an unpaired t-test. Results represent the mean (6
SEM) of three independent experiments. Note that both the wild-type
and MeOPN transferase mutant approach 100% survival in the presence
of EGTA.
doi:10.1371/journal.pone.0087051.g006
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mechanism. Studies are currently underway to determine if CRP
plays a role in the observed serum mediated killing and whether
other components of human serum bind preferentially to whole
cells and/or CPS lacking MeOPN relative to wild-type.
Given that MeOPN was found to influence both serum
resistance and invasion, we proceeded to examine the effects of
loss of MeOPN in vivo in both commensal (chicken) and
mammalian (piglet) colonization models. Loss of MeOPN in the
81–176 transferase mutant was found to have no effect on chicken
colonization. This is consistent with our recent results demon-
strating that C. jejuni NCTC 11168 fed to chickens along with
bacteriophages recognizing the MeOPN modification caused a
selection for C. jejuni variants without the CPS modification, but
did not change levels of C. jejuni colonization [12]. However,
MeOPN did influence colonization of piglets relative to wild-type
suggesting that this modification may be important in an infection
model, but it is still premature to make any definitive conclusions
since one model is using direct challenge while the other model
used competitive challenge. Combined, these results suggest that
MeOPN does not play a significant role in commensal coloniza-
tion, but may play a contributory role in pathogenesis. Maue et al.
[15] also recently reported that an 81–176 MeOPN biosynthesis
mutant showed a reduction in colonization levels compared to
wild-type 10 days post-infection in mice, another mammalian
model system. These studies suggest an interplay between the
benefits and disadvantages of MeOPN expression at various stages
of the infection process. It is interesting to note that, although the
presence of MeOPN had an effect on piglet colonization, MeOPN
modifications were not observed for any of the 19 C. coli strains
that we have examined by HR-MAS NMR to date [10], in spite of
the latter having a greater affinity for pigs as a host [27]. It will be
interesting to explore these relationships further and to examine a
broader range of isolates within each species [20]. It is also possible
that the primary role of MeOPN modification may in fact be in
the mediation of interactions between Campylobacter species and
phages and we have already demonstrated that this relationship
indeed exists for C. jejuni [11,12].
In a previous study investigating the ability of C. jejuni 11168H
to kill G. mellonella larvae, a MeOPN biosynthetic mutant showed a
marked decrease in larval killing relative to wild-type and
complementation of the mutation was able to restore wild-type
killing, suggesting that MeOPN has insecticidal activity against G.
mellonella [14]. Given that MeOPN appeared to be responsible for
the larval killing observed, we were interested in testing MeOPN
transferase mutants in the larval killing assay. The ability of both
the C. jejuni 81–176 and C. jejuni 11168H MeOPN transferase
mutants to kill G. mellonella larvae to wild-type levels was
unexpected, and suggested that MeOPN might be accumulating
to significant levels within the bacterial cell in our mutants.
However, we were unable to detect MeOPN or MeOPN
intermediates in metabolomics studies with the
cjj81176_1420::kanr/cjj81176_1435::camr mutant (results not
shown), so we examined potential insecticidal activity directly.
MeOPN-linked monosaccharides were synthesized and injected
into G. mellonella larvae, but none of the compounds showed any
level of insecticidal activity. To rule out the possibility that
MeOPN needs to be presented in a specific context to elicit the
insecticidal activity, purified CPS from 81–176 wild-type was
injected into G. mellonella, but again no insecticidal activity was
observed. It is worth noting that concentrated solutions were used
for both the MeOPN-linked monosaccharides and the purified
CPS injections, and therefore the MeOPN levels in these injections
are significantly higher than those in the C. jejuni injections. The
inability of MeOPN, MeOPN-linked oligosaccharides, or purified
81–176 CPS to induce larval killing provided conclusive evidence
that MeOPN does not have insecticidal activity as previously
suggested [14].
While it is possible that MeOPN could contribute indirectly to
larval killing by protecting the bacteria from the humoral
responses of the larval immune system, the ability of the
cjj81176_1420::kanr/cjj81176_1435::camr mutant to kill larvae at
wild-type levels suggests that larval killing by C. jejuni is MeOPN-
independent. The observation that MeOPN biosynthetic mutants
show a decreased ability to kill G. mellonella larvae as observed by
Champion et al. and by us in this study, is contrary to the other
findings, and suggests that MeOPN biosynthetic intermediates
may accumulate in the cytoplasm, causing the mutant to be less
able to survive inside the larvae, or that the mutation causes
Figure 7. Influence of MeOPN on colonization. (A) Colonization
levels of C. jejuni 81-176 wild-type and cjj81176_1420::kanr/
cjj81176_1435::camr (MeOPN transferase mutant) in a chicken coloniza-
tion model, 6 days post-infection. (B) Relative colonization levels of C.
jejuni 81-176 wild-type and the MeOPN transferase mutant in a
competitive piglet infection model. Note that no significant difference
was observed between strains in the chicken colonization model. In the
competitive piglet infection model, the MeOPN transferase mutant
displays a 5-fold reduction in colonization relative to wild-type
comparing the measured wild-type-to-mutant ratio of the inoculum
to the ratio recovered from the piglet intestine following infection
(p = 0.0005). Statistical significance was determined using a Man-
n2Whitney test. Horizontal bars represent median values.
doi:10.1371/journal.pone.0087051.g007
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downstream effects. Examination of all the mutants in this study
by RT-PCR demonstrated wild-type levels of gene transcripts
downstream of both MeOPN transferase mutants. In contrast,
mutants in the biosynthesis homologue cj1416 (which is also the
gene mutated by Champion et al.) show slightly less cj1415
transcription in both strain backgrounds. This is of relevance
because in our earlier study [10], we noted that cj1415 mutation
results in reduced CPS expression (based on the need to do
2816 NMR scans of the cj1415 mutant to see similar capsule
resonance signals compared to 256 scans for the wild-type and
other MeOPN mutants). So, the MeOPN biosynthesis mutants
may show higher levels of survival compared to the wild-types
because they are actually producing less CPS. Future studies to
elucidate the biochemical pathway for MeOPN biosynthesis and
to develop methods to accurately quantitate CPS expression will
be invaluable to advance our understanding of this unique
modification.
In summary, we have demonstrated that MeOPN modifications
are common within the Campylobacter genus, and especially
prevalent in species more closely related to C. jejuni, with the
possible exception of C. coli. We identified MeOPN biosynthesis
and transferase genes in C. jejuni 81–176, and generated mutants in
this pathway. We demonstrated that MeOPN moieties are not
inherently insecticidal against G. mellonella and that larval killing by
C. jejuni is not directly related to MeOPN. We further showed that
loss of MeOPN on the cell surface results in a drastic decrease in
serum resistance while enhancing invasion of Caco-2 cells. Loss of
MeOPN was found to have no effect on colonization in a
commensal chicken model, but showed a reduction in colonization
relative to wild-type in a piglet model, suggesting that MeOPN has
a contributory role in pathogenesis.
Supporting Information
Figure S1 RT-PCR analyses of genes located down-
stream from the Campylobacter jejuni mutated genes in
this study. Reverse Transcriptase PCR analyses of genes
downstream of the chromosomally disrupted genes indicates
Figure 8. MeOPN does not have insecticidal activity against Galleria mellonella. (A) Insecticidal activity of C. jejuni 81-176 wild-type,
cjj81176_1420::kanr/cjj81176_1435::camr (MeOPN transferase mutant), C. jejuni 81-176 kpsM::kanr (capsule mutant), C. jejuni 11168H wild-type, and C.
jejuni 11168H cj1421-1422::kanr (MeOPN transferase mutant). (B) Insecticidal activity of C. jejuni 81-176 wild-type, cjj81176_1415::kanr (MeOPN
biosynthesis mutant), C. jejuni 11168H wild-type, and C. jejuni 11168H cj1416::kanr (MeOPN biosynthesis mutant). (C) Insectidal activity of C. jejuni 81-
176 wild-type, C. jejuni 81-176 purified CPS, or MeOPN-containing compounds in a G. mellonella larval model. (D) Chemical structures of MeOPN-
containing compounds. Glc – methyl a-D-glucopyranoside; 2-MeOPN-Glc - methyl 2-O-(methylphosphoramidyl)-a-D-glucopyranoside; 6-MeOPN-Glc -
methyl 6-O-(methylphosphoramidyl)-a-D-glucopyranoside; Gal – methyl a-D-galactopyranoside; 2-MeOPN-Gal - methyl 2-O-(methylphosphoramidyl)-
a-D-galactopyranoside; 6-MeOPN-Glc - methyl 6-O-(methylphosphoramidyl)-a-D-galactopyranoside; CPS – purified capsular polysaccharide from 81-
176 wild-type. Survival percentages were significantly different between wild-type 81-176 and the kpsM::kanr mutant (p = 0.0031), the
cjj81176_1420::kanr/cjj81176_1435::camr and kpsM::kanr mutants (p = 0.0026), and between wild-type 81-176 and all tested MeOPN-containing
compounds (p,0.005 in all cases). Note that no statistically significant difference was observed between the wild-type and MeOPN transferase
mutant in either the 81-176 (p = 0.264) or 11168H (p = 0.063) strains. Results represent the mean (6SEM) of five independent experiments in (A) and
four independent experiments in (C) except for 81-176 CPS, which was the result of a single experiment.
doi:10.1371/journal.pone.0087051.g008
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similar transcript levels between wild-type and MeOPN transfer-
ase mutants for (A) cj1420 downstream of cj1421 and cj1422 in C.
jejuni 11168H and cjj81176_1419 downstream of cjj81176_1420 in
C. jejuni 81–176, and (B) cjj81176_1434 downstream of
cjj81176_1435 in the 81–176 background. Lower levels of
transcripts were observed in the MeOPN biosynthesis mutant
backgrounds relative to the wild-type strain for (C) cj1415
downstream of cj1416 in 11168H and cjj81176_1414 downstream
of cjj81176_1415 in 81–176.
(DOC)
Table S1 Accession numbers for the Cj1416-Cj1418
homologues and AtpA sequences from Campylobacter
species used in this study.
(DOC)
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